Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page
- Check2 days agoChange DetectedA new revision tag v3.5.4 was added, replacing the previous v3.5.3. This indicates the page has been updated to a newer revision.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, signaling a version update. This update is a technical patch and does not change the study data or presented content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision indicator updated to v3.5.2; previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded revision: v3.5.0. Deleted revision: v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the header. No changes to study content or page layout were observed.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision: v3.4.2 was added; the government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.